May 26 (Reuters) - BioClinica Inc, a U.S. pharmaceutical
contract research organization owned by buyout firm JLL
Partners, is exploring a sale that could value it at as much as
$1.3 billion, including debt, according to people familiar with
the matter.
Read more
No comments:
Post a Comment